MedReleaf signs supplier agreement with Shoppers Drug Mart
MARKHAM, ON, Dec. 21, 2017 /CNW/ – MedReleaf Corp. (TSX:LEAF) (“MedReleaf” or the “Company”) has announced today that it has entered into an agreement to become a medical cannabis supplier to Shoppers Drug Mart.
Subject to Health Canada’s approval of Shoppers Drug Mart’s application to be a licensed producer, under the terms of the agreement the Company will supply Shoppers Drug Mart with MedReleaf branded medical cannabis products. It is expected the products will be sold online, as Canadian regulations currently restrict the sale of medical cannabis in retail pharmacies.
From inception, MedReleaf has been focused on setting the standard for patient care in our industry and producing consistent, high quality medicine. With this agreement, we look forward to making our award-winning strains available as the trusted provider of premium cannabis-based pharmaceutical products to the largest pharmacy retailer in Canada.
Neil Closner, CEO of MedReleaf
About MedReleaf Corp.
MedReleaf sets The Medical Grade Standard™ for cannabis in Canada and around the world. The first and only ICH-GMP and ISO 9001 certified cannabis producer in North America, MedReleaf is an R&D-driven company dedicated to patient care, scientific innovation, research and advancing the understanding of the therapeutic benefits of cannabis. Sourced from around the world and carefully cultivated in one of two state of the art facilities in Ontario, MedReleaf delivers a variety of premium products to patients seeking safe, consistent and effective medical cannabis.
Before this cannabis stock news is here, it’s published to subscribers on 420 Investor.